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Abstract
Background: Cells respond to endoplasmic reticulum stress (ER) stress by activating the unfolded protein
response. To study the ER stress response in pancreatic b-cells we developed a model system that allows for
pathophysiological ER stress based on the Akita mouse. This mouse strain expresses a mutant insulin 2 gene
(C96Y), which prevents normal proinsulin folding causing ER stress and eventual b-cell apoptosis. A double-stable
pancreatic b-cell line (pTet-ON INS-1) with inducible expression of insulin 2 (C96Y) fused to EGFP was generated to
study the ER stress response.
Results: Expression of Ins 2 (C96Y)-EGFP resulted in activation of the ER stress pathways (PERK, IRE1 and ATF6) and
caused dilation of the ER. To identify gene expression changes resulting from mutant insulin expression we
performed microarray expression profiling and real time PCR experiments. We observed an induction of various ER
chaperone, co-chaperone and ER-associated degradation genes after 24 h and an increase in pro-apoptotic genes
(Chop and Trib3) following 48 h of mutant insulin expression. The latter changes occurred at a time when general
apoptosis was detected in the cell population, although the relative amount of cell death was low. Inhibiting the
proteasome or depleting Herp protein expression increased mutant insulin levels and enhanced cell apoptosis,
indicating that ER-associated degradation is maintaining cell survival.
Conclusions: The inducible mutant insulin expressing cell model has allowed for the identification of the ER stress
response in b-cells and the repertoire of genes/proteins induced is unique to this cell type. ER-associated
degradation is essential in maintaining cell survival in cells expressing mutant insulin. This cell model will be useful
for the molecular characterization of ER stress-induced genes.
Background
An increase in post-prandial blood glucose stimulates
pancreatic b-cells to secrete insulin, which mediates glu-
cose disposal into tissues such as muscle and fat. Glu-
cose also acutely stimulates insulin translation, which
replenishes the b-cell granules that have been depleted
during secretion [1]. The effect of glucose on translation
increases the protein folding load in the endoplasmic
reticulum (ER) of the b-cell, which may transiently
induce ER stress, a condition in which the folding capa-
city of the ER is insufficient for the level of newly
synthesized secretory proteins and results in the
accumulation of misfolded proteins. Such conditions are
sensed by ER localized stress sensors that mediate the
unfolded protein response (UPR) [2]. This results in a
transient reduction in translation efficiency to reduce
secretory protein load and induces chaperone capacity
and ER-associated degradation (ERAD). ER stress is
likely a physiological situation the b-cell transiently
experiences following feeding.
ER stress is also a feature of pathological conditions
associated with obesity and diabetes. Excess nutrients
(free fatty acids, glucose), amyloid deposits and inflam-
matory cytokines have all been shown to induce ER
stress in pancreatic b-cells [3]. These conditions induce
the UPR pathways that attempt to counteract ER stress.
However, chronic ER stress can lead to apoptosis induc-
tion [4], particularly in cell types with high secretory
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that perturbation of the UPR signaling pathways in vivo
leads to pancreatic b-cell death in animal models [5-7]
and humans [8] and mutations in the insulin molecule
in Akita mice results in ER stress-induced b-cell apop-
tosis [9,10]. In addition, it has been hypothesized that
chronic conditions associated with obesity over time
may lead to chronic ER stress-induced b-cell death
and depletion of b-cell mass that results in type 2
diabetes [11].
Thus, understanding how pancreatic b-cells deal with,
and respond to ER stress, is vital for understanding b-
cell biology under physiological and pathological condi-
tions. A detailed temporal analysis of the ER stress
response in b-cells has not been conducted. In addition
the molecular mechanism of ER stress-induced apopto-
sis is still, for the most part, unclear. As mentioned,
expression of folding-deficient proinsulin in the Akita
mouse leads to pancreatic b-cell death as a result of ER
stress and apoptosis [9]. Thus, the Akita mouse provides
a model of b-cell dysfunction resulting from ER stress
and affords a system to study the ER stress response
independently of using commonly used toxins such as
thapsigargin or tunicamycin.
To study the ER stress response in pancreatic b-cells
we developed a pancreatic b-cell culture system based
on the Akita mouse. Inducible expression of mutant
insulin 2 (C96Y) fused to EGFP [Ins2 (C96Y)-EGFP]
caused ER stress and apoptosis. In this study we exam-
ined the temporal gene expression response resulting
from induction of Ins2 (C96Y)-EGFP expression in INS-
1 b-cells and the role of ERAD in mediating cell
survival.
Methods
Cloning of the pTRE-Tight Insulin 2 (C96Y)-EGFP construct
Full-length wild-type mouse insulin 2 cDNA was ampli-
fied by PCR from pIns2 (WT)-EGFP, a fusion construct
obtained from Dr. Seiichi Oyadomari (New York Uni-
versity School of Medicine) [12]. The PCR fragment was
cloned into pCRII-TOPO vector (Invitrogen). Using the
QuikChange II XL Site-Directed Mutagenesis kit (Strata-
gene), a C96Y mutation was introduced into the insulin
2 cDNA. The mutation was confirmed by DNA sequen-
cing. Ins2 (C96Y) was cloned into the pEGFP-N1 vector
(BD Biosciences), the stop codon was removed and the
resulting fusion construct pIns2 (C96Y)-EGFP was
cloned into the NheI/NotI site of a pTRE-Tight vector
(Clontech).
Generation of an inducible Insulin 2 (C96Y)-EGFP
expressing INS-1 b-cell line
Initially a stable pTet-ON INS-1 clone was generated by
transfecting INS-1 cells (obtained from Dr. Claes
Wollheim, University of Geneva) [13] with the pTet-ON
plasmid and stable clones were selected following the
protocol provided (Clontech). Several clones were iso-
lated and tested by transient transfection using a lucifer-
ase reporter assay and the clone with the lowest basal
expression and highest doxycyline induction (INS1
pTet-ON #46) was used for generation of the double
stable cell line.
Double-stable Ins2 (C96Y)-EGFP expressing cells were
generated by co-transfection with a hygromycin resis-
tance plasmid and the pTRE -Ins2 (C96Y)-EGFP plasmid
into pTet-ON INS-1 #46 cells and selection by addition
of antibiotics: 200 μg/ml geneticin and 50 μg/ml hygro-
mycin B (Invitrogen). Individual clones were isolated and
tested for Ins2 (C96Y)-EGFP expression by western blot-
ting and immunofluorescence before and after induction
with doxycycline (2 μg/ml) for 24 h. A positive clone was
identified and fluorescence-activated cell sorting was
used to isolate the highest 20% of EGFP-positive cells in
this clonal population after induction with doxycycline
for 48 h. The cells were expanded in media without doxy-
cycline and referred to as clone #4S2.
Clone #4S2 cells were maintained in RPMI 1640 (11.1
mM glucose, 1 mM sodium pyruvate, 10 mM HEPES)
supplemented with 10% fetal bovine serum, 2 mM L-
glutamine, 55 μM b-mercaptoethanol with antibiotics
(100 units/ml penicillin and 100 μg/ml streptomycin)
and selection drugs (200 μg/ml G418 and 50 μg/ml
hygromycin).
Cell lysis and western blot analysis
Cells were washed in PBS and lysed in ice-cold lysis buf-
fer (1% Triton X-100, 20 mM HEPES, pH 7.4, 100 mM
K C l ,2m ME D T A ,1m MP M S F ,1 0μg/ml leupeptin,
and 10 μg/ml aprotinin, 10 mM NaF, 2 mM Na3VO4,
and 10 nM okadaic acid) for 15-20 min on ice. Lysates
were centrifuged at 13,000 rpm for 10 min at 4°C and
the protein concentration in the supernatant was deter-
mined using the BCA protein assay (Pierce). Equal
amounts of protein were resolved by SDS-PAGE and
immunoblotted as described previously [14]. For detec-
tion of insulin and cleaved caspase-3 by immunoblot-
ting, the samples were resolved using 4-12% NuPAGE
gels (Invitrogen). The following primary antibodies were
used: Phospho-eIF2a (Cell Signaling, #9721),
GADD153/CHOP (Santa Cruz, sc-575), KDEL (Stress-
Gen, SPA-827), insulin (Santa Cruz, sc-9168), insulin
(Dako, A0564), g-tubulin (Sigma, T6557), polyclonal
anti-GFP (obtained from Dr. James E. Rothman, Yale
University), monoclonal anti-GFP (Clontech, 632381),
cleaved caspase 3 (Cell Signaling, #9661S), ubiquitin
(Dako, Z0458), GM130 (Transduction Laboratories,
G65120), Hsp90 (Transduction Laboratories, 610418).
The polyclonal Herp antibody was provided by Dr.
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phis, TN).
Fluorescence microscopy
Cells were treated as described in the figure legends,
washed with PBS and fixed with 4% paraformaldehyde
in PBS for 20 minutes, washed with PBS and mounted
on glass coverslips using Fluoromount G (EM Sciences).
GFP fluorescence was visualized with a Zeiss laser scan-
ning confocal microscope. Clone #4S2 INS-1 cells were
treated as described in the figure legend, washed with
PBS and fixed with 4% paraformaldehyde in PBS for 20
minutes. The samples were processed for immunofluor-
escence microscopy as reported previously [15] and
immunostained with anti-ATF6 (TO13/14) antibody at a
1:100 dilution [14]. Quantitation of ATF6 staining in the
nucleus (marked by DAPI staining) was measured using
ImageJ Software. The average intensity in arbitrary units
in the nuclear area was determined. A minimum of 18
cells for all experimental condition were quantified and
the mean relative nuclear intensity is reported.
Cell Fractionation
Following doxycycline treatment for 72 hours, clone
#4S2 cells were washed with PBS and resuspended in
homogenization buffer: (0.25 M Sucrose, 4 mM HEPES,
1m MM g C l 2, 1.5 mM EDTA containing a complete
protease inhibitor tablet (Roche), 1 mM PMSF, 10 mM
NaF, 2 mM Na3VO4, 10 nM okadaic acid). Cells were
homogenized on ice with 12 strokes using a ball-bearing
cell homogenizer. The resulting homogenate was either
centrifuged at 100 000×g for 1.5 h to generate mem-
brane (pellet) and cytosol (SN) fractions, or subjected to
a 0.45 M to 2 M sucrose gradient for 18 h at 30 000
rpm, 4°C as outlined in [16]. After ultracentrifugation,
0.5 ml fractions were taken from the top of the gradient.
Electron Microscopy
Clone #4S2 cells were fixed in 2% glutaraldehyde (EM
Sciences) in 0.15 M Sorensen’s Phosphate Buffer (pH
7.4) (EM Sciences) for 30 min at room temperature.
The cells were washed twice with PBS and collected
into new tubes. Samples were prepared for transmission
electron microscopy by the electron microscopy facility
at Mount Sinai Hospital (Toronto). Briefly, the cell pel-
lets were fixed in 2% glutaraldehyde in 0.1 M sodium
cacodylate buffer (pH 7.3) for 2 h, rinsed with the same
buffer for 10 min, and post-fixed for 1.5 h in 1% OsO4.
After rinsing with the same buffer for 10 min, the cells
were dehydrated through a graded ethanol series up to
100% ethanol. The cells were then embedded in Spurr
r e s i ni na no v e na t6 5 ° Co v e r n i g h t .T h i ns e c t i o n s( ~ 1 0 0
nm) were cut with an RMC MT6000 ultramicrotome.
The sections were placed on copper grids and stained
with uranyl acetate (20 min) and lead citrate (10 min).
The grids were examined in a FEI Tecnai 20 transmis-
sion electron microscope and images were captured
using a Gatan Dualview digital camera.
RNA isolation and real-time PCR analysis
For real-time PCR analysis, total RNA was isolated from
cells untreated or treated with 2 μg/ml doxycycline for the
indicated times using TRIzol Reagent (Invitrogen) fol-
lowed by purification with RNeasy Mini Kit (Qiagen).
Total RNA was reverse transcribed to single-stranded
cDNA using the High-Capacity cDNA Reverse Transcrip-
tion Kit (Applied Biosystems). The resulting cDNA was
used for real-time PCR analysis by the TaqMan Gene
Expression system (Applied Biosystems) as described pre-
viously [14]. The following primers were obtained from
Applied Biosystems: Chop (Rn00492098_g1), Atf4
(Rn00824644_g1), Grp78 (Rn00565250_m1), Pdi
(Rn00564459_m1), Ero1a (Rn00593473_m1), Ero1b
(Rn01520960_m1), Sel1 (Rn00710081_m1), Erdj4
(Rn00562259_m1), Erdj5 (Rn01486444_m1), b-actin
(4352931E).
XBP1 splicing assay
Total RNA was isolated and rat XBP-1 cDNA was
amplified by RT-PCR (QIAGEN OneStep RT-PCR kit)
using primers that flank the intron excised by IRE1 exo-
nuclease activity as described previously [14].
siRNA transfection
Clone #4S2 cells were reverse transfected using Lipofec-
tamine RNAiMAX with 10 nM Herp siRNA (Invitrogen)
or a control siRNA (directed to bacterial b-galactosi-
dase) as described previously [17]. Twenty-four hours
later the cells were incubated or not with doxycycline
for 48 h then either lysed for western blot analysis or
for measurement of apoptosis using the cell death
ELISA kit (Roche).
Apoptosis assays
Cell apoptosis was measured using the cell death detection
ELISA kit (Roche) according to the instructions provided
in the kit. Briefly, clone #4S2 cells were seeded in 24-well
plates (200 000 cells/well) and treated as indicated in the
figure legends. Following the treatments, the cells were
lysed and oligonucleosomes in the cytoplasm (indicative of
apoptosis-associated DNA degradation) were quantified
according to the manufacturer’s instructions.
Terminal deoxynucleotidyl transferase-mediated dUTP
nick-end labeling (TUNEL) assays were performed using
the APO-BrdU TUNEL Assay Kit (Invitrogen). Clone
#4S2 cells were treated as described in the figure legend,
washed with warm PBS, trypsinized, then stained with
Fluor-647 dye-labeled anti-BrdU antibody, as described by
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ples were analyzed in a FACSCalibur flow cytometer (Bec-
ton Dickinson). To standardi z ee a c hs a m p l ea n ds e tt h e
quandrants, a negative control (INS-1 cells) and a positive
control (provided by the APO-BrdU TUNEL assay kit)
were used. GFP and the Fluor-647 dye-labeled anti-BrdU
antibody were excited using the FL1 (530/30) and FL4
(661/16) lasers, respectively.
Microarray analysis
Microarray expression profiling was used to assess the
global transcriptional changes in response to Ins2
(C96Y)-EGFP expression in clone #4S2 cells. Cells were
induced or not with doxycycline for 24 h, 48 h or 5
days and total RNA was isolated using TRIzol Reagent
(Invitrogen) followed by isolation using an RNeasy Mini
Kit (Qiagen). Assessment of RNA quality and microar-
ray analysis was performed at the University Health Net-
work (Toronto) microarray centre. Briefly, following
RNA quality assessment with an Agilent BioAnalyzer,
samples were reverse transcribed to cDNA. cDNA was
purified with a cDNA purification module from Affyme-
trix. Biotin was incorporated during in vitro transcrip-
tion and purified cRNA was then fragmented with a
chemical reaction. 15 μg of labeled and fragmented
cRNA was hybridized to Rat Genome 230 2.0 arrays
(Affymetrix Genechip) for 17 h at 45°C at 60 rpm. The
arrays were stained and washed using fluidic stations
with antibody and streptavidin phycoerythrin conjugate
solutions. All arrays are scanned using an Affymetrix
3000 7G scanner. The data sets were analyzed using
GeneSpring software (Version 7.1) (Agilent Technolo-
gies) and statistical analysis was performed using Gene-
Spring software according to the manufacturer’s
specifications. Genes with a minimum 2-fold difference
between control and doxycycline-treated cells in at least
two independent experiments at 24 h, 48 h and 5 days
are listed in the Additional file 1 and Additional file 2.
T h er a wm i c r o a r r a yd a t ah a sb e e nd e p o s i t e di nt h e
Gene Expression Omnibus (GEO) database (GSE22537).
Data analysis
Results are presented as mean ± SE. Statistical signifi-
cance between two experimental conditions was ana-
lyzed using a two-sample t-test assuming equal variance.
Data from several or more groups was analyzed by
ANOVA, followed by Tukey post hoc test. P < 0.05 was
considered statistically significant.
Results
Generation and characterization of the Insulin 2 (C96Y)-
EGFP stable INS-1 cell line
We first generated a stable pTet-ON INS-1 cell line that
allows for doxycycline-inducible protein expression. The
cell line was tested by transient transfection of the Ins2
(C96Y)-EGFP fusion construct in the presence or
absence of doxycycline. Fusion protein expression was
monitored by western blotting and fluorescence micro-
scopy. Expression of the fusion protein was doxycyline-
dependent and the fusion protein was excluded from
the nucleus and localized throughout the cell (Figure
1A, B). Interestingly, the expression of this construct
also resulted in the production of a lower migrating
band, which may be due to proteolytic cleavage of the
fusion construct in the cell (Figure 1A, arrow). A stable
Ins2 (C96Y)-EGFP pTet-ON cell line was generated by
co-transfection with a hygromycin resistance plasmid.
We isolated a clone with inducible mutant insulin
expression and fluorescence-activated cell sorting was
used to isolate EGFP-positive cells (top 20%) after 48 h
of doxycycline induction. The sorted cells (designated
clone #4S2) was expanded in media without doxycycline.
This clone exhibited low basal Ins2(C96Y)-EGFP expres-
sion and a marked induction following doxycycline
treatment (Figure 1C, D).
In addition to the full-length fusion protein other GFP
immunoreactive bands were observed in both TX-100
detergent whole cell lysates or lysates prepared by direct
lysis of the cells in SDS sample buffer (Figure 2A).
These fragments are likely degradation products of the
full-length fusion protein and most of the fragments
could not be efficiently immunoprecipitated using an
anti-GFP antibody (Figure 2B). Cells were homogenized
and subjected to membrane and cytosol fractionation.
Whereas the full-length Ins2 (C96Y)-EGFP fusion pro-
tein could be detected in the membrane fraction, the
degradation fragments were present exclusively in the
cytosol fraction (Figure 2C). The full-length fusion pro-
tein was detected in ER fractions by sucrose density
fractionation while the lower migrating degradation
fragments were present exclusively in the cytosol frac-
tions (Figure 2D). Since no degradation fragments were
present in microsome fractions it is likely that degrada-
tion of the full-length fusion protein occurs in the cyto-
sol. The presence of some soluble ER lumenal GRP78
(and Ins2 (C96Y)-EGFP) in cytosolic fractions in the
sucrose gradient may be due to some leakage during
cell homogenization.
We examined the morphology of the stable cell line by
electron microscopy before and after doxycycline induc-
tion. In non-induced cells a normal ER morphology was
observed (Figure 3A, B), whereas cells expressing Ins2
(C96Y)-EGFP for three days had an altered ER morphol-
ogy (Figure 3C, D). The ER was expanded and dilated
compared to control cells. The ER tended to be even more
severely dilated in many of the cells after six days of
mutant insulin expression (Figure 3E, F). This morphology
is characteristic of unfolded protein accumulation and ER
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mouse [9]. In addition, apoptotic cells were observed in
the population expressing the fusion protein (Figure 3C,
arrowheads).
The ER stress response to Insulin 2 (C96Y)-EGFP
expression
The morphological analysis indicated that the expression
of Ins2 (C96Y)-EGFP was causing an accumulation of
this protein in the ER and causing ER stress. We thus
examined whether doxycycline-induced expression of
Ins2 (C96Y)-EGFP was activating UPR signaling path-
ways. Ins2 (C96Y)-EGFP expression was induced for
various times and activation of the ER stress-sensing
pathways was monitored. Spliced XBP-1, indicative of
IRE1a activation, was detected after 24 h of doxycyline
induction and similar levels of spliced XBP-1 were pre-
sent throughout the induction period for up to 7 days
(Figure 4A, shows a representative example up to 5 days
of induction). The levels of phospho-eIF2a, indicative of
PERK activation, were also increased (Figure 4B), as
were the levels of active ATF6-p50 (Figure 4C). Thus,
expression of the mutant insulin causes measurable acti-
vation of the ER stress pathways mediated by IRE1a,
PERK and ATF6.
To examine the global transcriptional response to
mutant insulin expression we performed microarray
analysis of the gene expression changes following Ins2
-D o x +  D o x B A
24h 3d 48h 6d No Dox (6d)
C
D
Figure 1 Induction of insulin 2 (C96Y)-EGFP protein expression in pTet-ON INS-1 cells by doxycyline. A-B. pTet-ON INS-1 #46 cells were
transiently transfected with pTRE-Tight Ins2 (C96Y)-EGFP construct in the presence or absence of 2 μg/ml doxycycline (Dox) for 48 h. In (A), cells
were washed in PBS, lysed and 10 μg of protein were resolved by SDS-PAGE and immunoblotted using antibodies to insulin and GFP. In (B) the
cells were washed in PBS, fixed and mounted. GFP fluorescence was visualized using a laser confocal fluorescence microscope. C-D. A stable Ins2
(C96Y)-EGFP expressing INS1 clone (Clone #4S2), generated as described in the methods, was untreated (-Dox) or treated with 2 μg/ml
doxycycline (+Dox) for the times indicated. The cells were washed in PBS, lysed and an equal amount of protein per condition were resolved by
SDS-PAGE and immunoblotted using antibodies to GM130 and GFP (C). In (D), EGFP fluorescence in fixed cells was visualized by confocal
fluorescence microscopy.
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24 h, 48 h and 5 days of doxycycline treatment from
three independent experiments, reverse transcribed and
hybridized to Affymetrix rat genome arrays. Gene
expression changes were examined and those that were
upregulated or downregulated by 2-fold after doxycy-
line-induced expression of Ins2 (C96Y)-EGFP are listed
in the Additional files 1 and 2. Following 24 h induction
45 genes were upregulated and 5 were downregulated.
After 48 h induction 86 genes were upregulated and 37
downregulated, whereas 68 genes were induced and 56
reduced after 5 days induction. These numbers include
genes (both well-substantiated and transcribed loci) that
were identified as statistically significant in at least two
of three experiments.
Shown in Table 1 are a selected list of genes induced
>2-fold in at least two independent experiments at the
various time points. This list includes genes involved in
the UPR response, protein folding and modification,
ERAD and protein transport. Several patterns emerged
from this analysis. After 24 h of mutant protein expres-
sion, the majority of the genes induced were ER loca-
lized chaperone genes (Erdj4/Dnajb9, P58
IPK /Dnajc3,
Erdj3/Dnajb11, Fkbp11) as well as the ERAD-associated
genes (Herp and Sel1). The Sdf2l1 gene was the most
abundantly induced gene present in all three experi-
ments. In addition, the Atf4 and Chop transcription fac-
tors, target genes of the PERK-eIF2a pathway, were also
induced in two out of three experiments at this early
time point. Trib3 (Trb3), a putative target gene of the
CHOP transcription factor [18], was also induced in two
out of three experiments.
Following 48 h of mutant protein expression a greater
number of genes were induced compared to 24 h (Table
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C
Figure 2 Insulin 2 (C96Y)-EGFP is localized to the ER while degradation products appear in the cytosol. A. Clone #4S2 cells were
untreated (-Dox) or treated with 2 μg/ml doxycycline (+Dox) for 48 h. Following the treatments, the cells were washed in PBS and lysed in
either 1% TX-100 lysis buffer (with protease inhibitors) or directly in SDS sample buffer with b-mercaptoethanol. Equal amounts of protein (or
equal volumes) were resolved by SDS-PAGE and immunoblotted using antibodies to GM130 or GFP. B. Cells were untreated (Control) or treated
for 48 h with 2 μg/ml doxycycline before lysis and immunoprecipitation with anti-GFP or control mouse IgG antibodies. The entire precipitate
(pellets; P) and 10 μg of the supernatant (SN) were resolved by SDS-PAGE and immunoblotted using an anti-GFP (rabbit, polyclonal) antibody. C.
Cells were treated with 2 μg/ml doxycycline for 72 h, washed in PBS and homogenized in sucrose buffer as described in the methods. The
homogenate was fractionated into membrane (M) and cytosol (C) fractions. D. Cells were treated with 2 μg/ml doxycycline for 72 h, washed in
PBS and homogenized in sucrose buffer as described in the methods. The homogenate was fractionated on a linear sucrose density gradient
and an equal volume of each fraction was resolved by NuPAGE and immunoblotted using antibodies to HSP90, GRP78, GFP and insulin.
Hartley et al. BMC Cell Biology 2010, 11:59
http://www.biomedcentral.com/1471-2121/11/59
Page 6 of 181 and Additional files 1 and 2). Additional chaperone
genes (Pdia2, Pdia3 and Pdia4) were upregulated. The
levels of the Chop transcription factor were also signifi-
cantly higher than at the 24 h time point. However, the
most abundantly induced gene at 48 h of mutant pro-
tein expression was Trib3 (Trb3) ,ag e n ew h o s ep r o t e i n
product has been implicated in apoptosis among other
cellular processes [18,19]. At this time point other genes
including protein transport genes and transcription fac-
tors were also upregulated. By 5 days of mutant protein
expression the gene expression changes as monitored by
microarray was more variable between experiments than
at the 48 h time point. However, all the chaperone
genes observed at earlier time points were still elevated
and additional PDI family member genes (Pdia6 and
Txndc4) were induced. The levels of Trib3 were lower
B
D C
E F
A
Figure 3 Effect of insulin 2 (C96Y)-EGFP expression on ER morphology. Clone #4S2 cells untreated (A, B) or treated with 2 μg/ml
doxycycline for 3 days (C, D) or 6 days (E, F) were washed in PBS and fixed. The cells were processed for transmission electron microscopy as
described in the methods. ER structures in uninduced cells (A, B, arrows), and distended ER structures in mutant insulin expressing cells following
doxycyline-induction (D-F, arrows) are indicated. The presence of apoptotic cells was evident in doxycyline-induced cells (C, arrowheads).
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Interestingly, the levels of Sdf2l1, Creld2 and Armet
remained highly induced throughout the time course of
mutant protein expression.
Although some of the gene expression changes found
were expected based on the ER stress response induced
in other models (discussed later), some genes predicted
to be increased were not observed, such as the ER cha-
perone genes Grp78 and Pdi. Microarray expression
profiling can lead to false negatives due to inefficient
probes. We therefore examined the mRNA and protein
levels of several well established targets of the UPR by
real-time PCR and western blotting. An increase in the
mRNA levels of Grp78, Pdi, Chop and Sel1 was
observed in response to doxycycline-induced mutant
insulin expression (Figure 5A-D). The latter two changes
substantiate the microarray results. However, both
Grp78 and Pdi are significantly upregulated early (within
24-48 h) of mutant insulin expression. This was not
detected by microarray, which does produce false nega-
tive results in this case. Consistent with the gene expres-
sion data, GRP78 and CHOP protein levels were also
induced by Ins2 (C96Y)-EGFP expression (Figure 5E-F).
Interestingly, thapsigargin treatment for 6 h induced
higher expression of CHOP protein in clone #4S2 than
in parental INS-1 cells, suggesting that clone #4S2 are
more susceptible to ER stress (Figure 5F).
We performed additional real-time PCR analysis of
other putative ER stress response genes to validate some
of the microarray results (Figure 6). Consistent with the
microarray data (Table 1) we observed an induction of
Erdj4,b u tn o tt h er e l a t e dg e n eErdj5/Dnajc10, despite
the fact that the latter has been shown to be induced by
ER stress in other cell types [20,21]. In addition,
A B
3d 6d 6d
+Dox -Dox
6h
Con Tg
INS-1 Clone #4 S2
GM130
p-eIF2α
Time
0
5
10
15
20
25
30
35
40
45
50
Cont DTT 24 h 48 h 5-day
R
e
l
a
t
i
v
e
 
n
u
c
l
e
a
r
 
i
n
t
e
n
s
i
t
y
Doxycycline
C
* *
*
Con
1h 24h 48h 72h
+Dox
Clone #4 S2
uXBP-1
sXBP-1
INS-1
Tg
Time
Con
5d
Figure 4 ER stress signaling pathways are activated by insulin 2 (C96Y)-EGFP expression. Clone #4S2 cells were untreated (-Dox) or
treated with 2 μg/ml doxycycline (+Dox) for the times indicated. Control INS-1 cells exposed to thapsigargin (Tg) or dithiothreitol (DTT) were
used as a positive control. A. RNA was isolated from the cells and XBP-1 cDNA was amplified by RT-PCR. The unspliced form of XBP-1 (uXBP-1,
480 bp) and spliced form of XBP-1 (sXBP-1, 454 bp) are indicated. B. Clone #4S2 cells were treated as in (A), washed in PBS and lysed. Equal
amounts of protein were resolved by SDS-PAGE and immunoblotted with anti-phospho-eIF2a and GM130 antibodies. C. Clone #4S2 cells were
treated with 1 mM dithiothreitol (DTT) for 30 min. or doxycycline as indicated and fixed for immunofluorescence labeling with anti-ATF6
antibody. Nuclear fluorescence of ATF6 was quantified as described in the methods.
Hartley et al. BMC Cell Biology 2010, 11:59
http://www.biomedcentral.com/1471-2121/11/59
Page 8 of 18although not detected by microarray, we observed
induction of Ero1b,b u tn o tEro1a (Figure 6C, D). The
former, but not the latter, has been reported to be ER
stress-inducible, which is consistent with our results
[22]. It is important to note that doxycyline at the same
concentration used in these studies added to a parental
INS-1 cell line does not induce any changes in Grp78 or
Chop mRNA or protein levels (results not shown), indi-
cating that the changes observed are due to Ins2
(C96Y)-EGFP expression and not the small molecule.
Overall, the microarray and real-time PCR results
show that Ins2 (C96Y)-EGFP expression causes the
induction of many established ER stress response genes,
although there is clearly some selectivity in the genes
induced.
Induction of apoptosis following Insulin 2 (C96Y)-EGFP
expression
As shown in Table 1, genes associated with apoptosis
such as Chop and Trib3 were already upregulated after
24 h of mutant insulin expression and the expression
levels were even greater after 48 h. We thus examined
whether doxycycline-induced expression of Ins2 (C96Y)-
EGFP induces apoptosis. By light microscopy many of
the cells appear rounded in comparison to the control
cells at about 72 h of mutant protein expression, indica-
tive of dead or dying cells (Figure 7A, arrows). To con-
firm that cell death was due to apoptosis we measured
cytoplasmic DNA-associated histone complexes using a
sensitive ELISA assay and found that 48 h to 7-day
treatment of doxycycline causes apoptosis in a time-
Table 1 Selected list of induced genes comparing uninduced cells to cells expressing insulin 2 (C96Y)-EGFP for 24 h,
48 h and 5 days identified by Affymetrix rat genome arrays
Gene Name Entrez Gene ID Putative Function Fold Change
24 h 48 h 5d
Protein modification/folding
Sdf2l1 680945 O-mannosylation? 5.7 4.7 10.9
Fkbp11 300211 Peptidyl-prolyl isomerase 2.9 3.9 4.3
Dnajb9/Erdj4 24908 Protein folding 2.5 3 3.1
Dnajc3/P58
IPK 63880 Protein folding 2.3 2.8 4.2
Dnajb11/Erdj3 360734 Protein folding 2.2 2.4 3
Pdia2 287164 PDI family, isomerase 3.1 2.7
Pdia3/Erp57 29468 PDI family, isomerase 3.2 3.2
Pdia4/Erp72 116598 PDI family, isomerase 3.1 3.1
Hspa5/Grp78 25617 ER Protein folding 2.6
Pdia6/P5 286906 PDI family, isomerase 3
Txndc4/Erp44 298066 PDI family, isomerase 2
ER stress-inducible
Herp 85430 ERAD 3.3 4.3 3.5
Sel1h 314352 ERAD 2.5 2.7 2.6
Atf4 79255 Transcription factor 2.7 3
Chop/Gadd153 29467 Transcription factor 2.5 3.5 2.7
Trib3/Trb3 246273 11.5 19.8 6.7
Transcription factors
Mist1 25334 Transcription factor 2.9 3.2 3.7
Atf5 282840 Transcription factor 2.4 3.3
Protein transport
Kdelr3 315131 Vesicle transport 2.1 2.9 3.8
Tmed3 300888 Vesicle transport 2.4 2.8
Selected others
Creld2 362978 ER Protein folding? 3.6 3.6 7
Armet 315989 2.8 2.8 3.9
Myo1g 289785 Motor protein 2.3 2.9 2.5
Ell3 296102 RNA polymerase II-like 3 2.1 2.2 3.6
Magt1 116967 Magnesium transporter 2.1 2.3 2.4
Oat 64313 Ornithine aminotransferase 2 2.3 2.8
Mean fold change from three independent experiments for each time point is shown. Bold indicates the gene was induced in at least 2 independent
experiments and italics indicates average induction value of multiple probes for the same gene.
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Page 9 of 18dependent manner (Figure 7B). Western blot analysis
also revealed a detectable increase in cleaved caspase-3
by ~3 days of mutant protein expression (Figure 7C).
To identify the relative percentage of apoptotic cells in
the mutant insulin expressing population we monitored
apoptosis by TUNEL assay using FACS analysis, which
also allowed for the detection of mutant protein expres-
sion by the GFP fluorescence. Addition of doxycycline
increased GFP fluorescence depicted on the y-axis, com-
pared to control cells not treated with doxycycline (Fig-
ure 7D). The percentage of apoptotic (TUNEL positive)
cells is low and comparable to control cells following 24
h doxycycline induction (Figure 7D, left panels). How-
ever, mutant protein expression following 5 days of dox-
ycycline treatment leads to the induction of apoptosis in
approximately 14% of the population (Figure 7D, right
panel).
The extent of apoptosis observed in the population
expressing Ins2 (C96Y)-EGFP even for extended periods
(>5 days) seemed rather low. We hypothesized that the
ER stress response in these cells, particularly the induc-
tion of ERAD genes, might be responsible for
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Figure 5 Expression of insulin 2 (C96Y)-EGFP induces the mRNA and protein of known ER stress response genes. Clone #4S2 cells were
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insulin and preventing accumulation to toxic levels. We
therefore examined whether inhibiting the ERAD system
might sensitize the cells to cell death. As a first
approach we inhibited proteasome function using lacta-
cystin. Cells were induced with doxycycline for 48 h
then treated or not with lactacystin and cell apoptosis
was monitored. Inhibition of the proteasome resulted in
a significantly higher percentage of apoptotic cells in the
population (Figure 8A). This was also accompanied by
an increase in the cellular levels of ubiquinated proteins
(Figure 8B, left panel) and an increase in the levels of
Ins2 (C96Y)-EGFP fusion protein and degradation
fragments (Figure 8B, right panel). These results sug-
gest that inhibiting ERAD increases misfolded protein
levels and enhances ER stress-induced apoptosis.
As an alternative approach for inhibiting ERAD we
targeted the Herp protein which was found to be
induced early by mutant insulin expression (Table 1).
Herp has been implicated in ERAD of certain misfolded
proteins [23], although whether it is required for mis-
folded insulin degradation has not been examined. We
first confirmed that the Herp protein is induced in
response to mutant insulin expression (Figure 9A). To
perturb ERAD function, we blunted the induction of
Herp expression using siRNA (Figure 9B, C). Reducing
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Page 11 of 18Herp expression by about 40-50% resulted in an
increase in the steady-state levels of the mutant insulin
protein, even in the absence of doxycycline induction
(Figure 9B). This also increased apoptosis levels in the
population relative to control siRNA transfected cells
(Figure 9D). With doxycyline induction for 48 h the
levels of Ins2 (C96Y)-EGFP in Herp siRNA-treated cells
was increased relative to control siRNA transfected cells,
but the effect was small (Figure 9B). In some experi-
ments we also observed a reduction in the degradation
fragments in Herp siRNA-treated cells (see Figure 9B,
Expt.#2, low exposure), but this was not a consistent
finding (Figure 9B, Expt.#1). The inconsistent results
may be due to the inefficient knock-down of the Herp
protein achieved in these studies. Regardless, the levels
of apoptosis in the population depleted of Herp
A
72h Dox Control
C B
D
Figure 7 Expression of insulin 2 (C96Y)-EGFP induces apoptosis. A. Clone #4S2 cells were treated or not with 2 μg/ml doxycycline for 72 h,
fixed and imaged by differential interference contrast microscopy. Potentially apoptotic cells with a rounded morphology are indicated (arrows).
B-D. Clone #4S2 cells were treated with 2 μg/ml doxycycline for the indicated times. B. Following the treatments, the cells were lysed and
apoptosis was measured using a cell death detection ELISA kit (Roche) as described in the methods. Shown are the mean ± SE of 4
independent experiments. *p < 0.05. C. Cells were washed in PBS, lysed and equal amounts of protein were resolved by NuPAGE and
immunoblotted using antibodies to cleaved caspase-3 and g-tubulin. D. Cells were fixed and labeled with Alexa Fluor 647 dye-labeled anti-BrdU
antibody. Cells were analyzed by flow cytometry; the FL1 laser excites GFP, whereas FL4 excites Fluor 647. Cells in the upper left and right
quadrants were classified as mutant insulin expressing, cells in the upper and lower right quadrants were classified as apoptotic. The total
number of cells examined is shown below each chart, and the percentage of cells in each quadrant is indicated.
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Page 12 of 18expression was significantly higher compared to control
siRNA-transfected cells as measured by cleaved caspase
3 levels (Figure 9E). Altogether, these results suggest
that the mutant insulin is an ERAD target and that
Herp function is required for its degradation and that
reducing Herp levels increases mutant insulin levels and
sensitizes the cells to apoptosis.
Discussion
The UPR is an essential process by which cells respond
to the accumulation of misfolded protein in the ER.
This can occur either physiologically, as a result of
acute secretory protein load, or as a result of pathologi-
cal insults that may impede protein folding capacity.
The basic ER stress response is well established invol-
ving an acute translational attenuation followed by the
upregulation of a transcriptional profile that includes ER
chaperone genes, ERAD components, protein transport
genes, among others [2]. However, it is probable that
different cell types have a unique profile of upregulated
genes that are dependent on a particular cells function
and the secretory proteins it produces. The goal of the
present study was to examine the ER stress response in
the insulin producing pancreatic b-cell. To do this we
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Page 13 of 18developed a pancreatic b-cell culture model with induci-
ble expression of a folding-deficient insulin fusion pro-
tein based on the proinsulin mutation found in the
Akita mouse [9]. The rationale behind this approach
was that regulated expression of a single misfolded pro-
tein would allow for a temporal characterization of the
UPR in b-cells. This may reflect the ER stress response
to physiological conditions (acute insulin synthesis) and
potentially a chronic response induced by pathological
conditions occurring in type 2 diabetes (chronic insulin
biosynthetic demands coupled with the effects of
chronic free fatty acids, glucose and cytokines that
induce ER stress).
Using the tetracycline/doxycycline-regulated expres-
sion system we created a double stable INS-1 cell clone
with stable integration of the pTet-ON regulatory
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Page 14 of 18plasmid and the Ins2 (C96Y)-EGFP plasmid driven by
the Tet/Dox-responsive promoter. The EGFP tag was
used in order to facilitate selection of stable clones, as
well as for sorting of the positive clones for cells with
high expression of the Ins2 (C96Y)-EGFP fusion protein.
In the clone selected for the studies basal expression of
the mutant insulin is low, although detectable. Following
doxycyline addition the mutant insulin is markedly
induced by 24 h, reaching maximal expression by ~72 h
and expression is maintained for several days. Expres-
sion of the mutant insulin fusion protein leads to a
swollen ER lumen that is readily detectable in many
cells and is indicative of misfolded protein accumulation
and a stressed ER. This result is similar to the pheno-
type observed in the b-cells of Akita mice [9]. As
expected, expression of folding-deficient Ins 2 (C96Y)-
EGFP fusion protein resulted in the induction of UPR
pathways (PERK, IRE1 and ATF6).
To analyze the ER stress response in the cell line we
performed microarray expression profiling and real time
PCR analysis at various times following mutant protein
expression. We chose time-points of Ins2 (C96Y)-EGFP
expression when no significant apoptosis was observed
(24 h) and longer expression time points (48 h and 5
days), when apoptotic cell death was detectable. After
24 h, 45 genes were induced, while the number of
induced genes was substantially increased after 72 h (86)
and 5 days (68). Interestingly, the number of downregu-
lated genes was also increased at the longer incubation
times (37 and 56 after 48 h and 5 d of doxycycline
induction, respectively). This may reflect the observation
that prolonged activation of IRE1a can result in relaxed
specificity and cleavage of cellular mRNAs [24], result-
ing in the downregulation of some genes as a result of
prolonged ER stress.
After 24 h of Ins2 (C96Y)-EGFP expression the most
consistently induced genes were ER resident chaperones
and co-chaperones (Grp78, Erdj4, P58
IPK , Erdj3,
Fkbp11) and an ERAD component (Herp). The J-domain
containing co-chaperones (Erdj4, P58
IPK ) have been
shown to be induced by ER stress in various cell types
[20,25-32]. Recently, P58
IPK and ERdj3 have been found
to interact with misfolded proteins in the ER prior to
recruitment of the chaperone GRP78 [26,29,30,32]. In
addition, these proteins have also been implicated in tar-
geting misfolded proteins for degradation via the ERAD
system [20,28]. Thus, expression of misfolded insulin
causes the induction of chaperone proteins early in an
effort to fold the mutant insulin. These chaperones are
maintained at high levels throughout the time course of
mutant insulin induction and some may assist in degra-
dation of the misfolded molecule once folding is found
to be futile (discussed below). The importance of P58
IPK
function in normal pancreatic b-cells in vivo is
evidenced by increased pancreatic b-cell apoptosis and
hyperglycemia in knock-out mice [33]. However, the
detailed molecular function of these co-chaperones in b-
cells has not been examined to date.
Interestingly, although there are six mammalian DNAJ
domain-containing proteins, we only found a subset to
be induced by mutant insulin expression. Notable
among those that were not upregulated is ERdj5.
Recently, expression of a folding-deficient version of the
secreted protein surfactant protein C in HEK293 cells
caused the induction of various ER stress response
genes, including Erdj4 and Erdj5,w h i c hw e r es h o w nt o
be required for degradation of the folding-deficient sur-
factant protein C [20]. Surfactant protein C, like proin-
sulin, contains disulfide bonds, but is not glycosylated.
Thus, it is interesting that we do not observe induction
of Erdj5 in b-cells expressing folding-deficient proinsu-
lin. A recent report, however, has shown that ERdj5 can
interact with EDEM proteins and is required for redu-
cing disulfide bonds on misfolded, glycosylated proteins
prior to retrotranslocation [21]. EDEM genes were not
detected in the microarray analysis, suggesting that
proinsulin may not require EDEM or ERdj5 for its
degradation.
Comparing the UPR response observed in our study to
ER stress responses in other cell types shows that some
of the early chaperone genes induced by mutant protein
expression are not observed in other systems. For exam-
ple, tunicamycin treatment of neuroblastoma cells [34]
or expression of a retroviral protein in astrocytes, which
induces ER stress [35], did not cause an upregulation of
Erdj4, P58
IPK , Erdj3,o rFkbp11.I m p o r t a n t l y ,a l lo f
these genes have been shown to be induced by ER stress
caused by prolonged palmitate exposure in cultured
mouse MIN6 cells [36]. Saturated FFAs have been
shown to induce ER stress in pancreatic b-cells and this
may contribute to b-cell dysfunction [15,36,37]. In addi-
tion, a recent proteomic study examining islets from a
diabetic insulin resistant mouse model has shown that
the protein (and mRNA levels) of some of these (P58
IPK,
ERdj3, Fkbp11) are upregulated [38]. Thus, the induc-
tion of these genes/proteins are likely important cell
protective ER stress response proteins in b-cells and a
detailed biochemical analysis of their function in med-
iating proinsulin folding and/or degradation is
warranted.
In addition to ER chaperone genes and ERAD compo-
nents, several other genes were found to be induced
early as a result of Ins2 (C96Y)-EGFP expression,
including Sdf2l1, Armet and Creld2.A l lt h r e ew e r e
abundantly upregulated at both early and late time
points. The exact functions of the protein products of
these genes in the ER stress response is largely unde-
fined, although these proteins have also been reported
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Page 15 of 18to be induced by ER stress-inducing compounds such as
tunicamycin in other cell types [39-41].
The appearance of prominent lower migrating bands
recognized by anti-GFP antibodies indicates that the
Ins2 (C96Y)-EGFP fusion protein is being degraded.
Similar cleavage products have been detected with wild-
type proinsulin tagged with GFP at the C-terminus and
was suggested to occur from non-specific cleavage of
the fusion protein at some point along the secretory
pathway [42]. In the case of the Ins2 (C96Y)-EGFP the
cleavage products are not efficiently immunoprecipitated
by anti-GFP antibodies and are not detected in ER frac-
tions. Thus, the smaller migrating bands recognized by
GFP antibodies are likely degradation products of pro-
teolysis occurring in the cytoplasm. The full-length
mutant insulin fusion protein appears to be inaccessible
to the secretory pathway and is retained in the ER,
which is consistent with a report showing that the C96Y
mutation in proinsulin results in misfolding of the mole-
cule and retention in the ER [42].
The Ins2 (C96Y)-EGFP fusion protein is likely
degraded by the ubiquitin-dependent ERAD system. The
ERAD-associated genes Herp and Sel1 were induced by
mutant insulin expression, which is consistent with the
finding that Sel1 is upregulated in Akita islets [43]. Inhi-
biting the 26S proteasome resulted in an increase in the
levels of Ins2 (C96Y)-EGFP and sensitized the cells to
cell death. This was also the effect observed by reducing
Herp expression using siRNA, a protein recently shown
to be required for the degradation of a disulfide bond-
containing mutant version of the kappa light chain [23].
The process of Ins2 (C96Y)-EGFP degradation however,
may be quite complex. If the proteasome was responsible
for generating the degradation fragments observed (Fig-
ure 2) than inhibiting the proteasome would be expected
to not affect the steady-state levels of these fragments;
new fragments would be prevented from being generated
from Ins2 (C96Y)-EGFP and fragments already present
prevented from being degraded. However, most degrada-
tion fragments were actually increased by proteasome
inhibition (Figure 8B), suggesting that other proteases
may be responsible for generating the degradation frag-
ments that are then targeted for ubiquitin-dependent
degradation.
It should be pointed out that although expression of the
Ins2 (C96Y)-EGFP fusion protein induces ER stress and
degradation of the fusion protein, due to the presence of
the EGFP tag the degradation of the fusion construct may
not be identical to the degradation of untagged proinsulin
C96Y. Furthermore, it is possible that the ER stress
response elicited by untagged proinsulin C96Y is different
compared to that of Ins2 (C96Y)-EGFP. These possibilities
should be explored in future studies.
This model system also allowed us to examine
potential gene expression changes associated with ER
stress-induced cell death. An upregulation of the pro-
apoptotic transcription factor Chop and one of its tar-
get genes (Trib3) was evident by 24 h of Ins2 (C96Y)-
EGFP expression, which is indicative of PERK pathway
activation and is likely to be a normal physiological
response. At this time point no significant apoptosis is
detected in the population. After 48 h of mutant insu-
lin expression however, the levels of Chop and Trib3
were even higher, which coincided with detection of
apoptosis in the population. Thus, a sustained increase
in the levels of CHOP and TRIB3 proteins may tilt
cells towards apoptosis induction. Pancreatic b-cells of
CHOP-deficient heterozygous Akita mice are partially
protected from cell death [12], although clearly there
are other factors also involved. In the mutant insulin
expressing cell line the most highly induced gene after
48 h was Trib3. Recently, the TRIB3 protein has been
shown to be induced by the PERK-ATF4-CHOP path-
way and has been implicated in mediating apoptosis
[18,19] and in hyperglycemia-induced pancreatic b-cell
death [44]. The mechanism of this effect, however, is
unclear. Whether the TRIB3 protein is responsible for
apoptosis induction and how much of the apoptosis is
TRIB3-dependent in this model system requires future
study.
Despite the abundant upregulation of Chop and Trib3
in response to mutant insulin expression, the level of
apoptotic cells in the population remained rather low,
even after long term expression of the mutant construct.
This is likely because one of the main cell protective
effects induced by the UPR, ERAD, is also upregulated.
Inhibition of ERAD by inhibiting the cytosolic protea-
some or inhibiting Herp upregulation sensitizes the cells
to apoptosis, supporting the notion that the ERAD path-
way may support cell survival by degradation of mis-
folded insulin.
Conclusions
The b-cell model of ER stress described in this study
has allowed for a detailed characterization of the ER
stress response induced by misfolded Ins2 (C96Y)-
EGFP expression and for the identification of both cell
protective and possible cell destructive genes. The
repertoire of genes/proteins induced is unique to this
cell type compared to the UPR induced in other cell
types, perhaps reflecting the unique role of b-cells to pro-
duce insulin. The Herp protein and ER-associated degra-
dation is essential for maintaining cell survival in cells
expressing mutant insulin. The cell model developed here
will be useful in studies examining the function of ER
stress-induced genes.
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Additional file 1: This file lists all the genes whose expressed
increased or decreased >2-fold in at least two of three independent
experiments. Excel file presenting all of the Affymetrix probes whose
expression was increased or decreased by at least 2 fold between
doxycycline-treated vs. control, untreated INS-1 clone #4S2 cells. Data
from 3 independent experiments (N = 1, N = 2, N = 3) for all
doxycycline treatment time points (24 h, 48 h, and 5 days) is shown.
Note that gene descriptions for these tables are provided by the
GeneSpring software. Bold indicates probes whose expression was
changed in all three experiments, while regular font indicates genes that
were changed in at least 2 of 3 independent experiments. The primary
data files for the microarray experiments have been deposited in the
Gene Expression Omnibus (GEO) database (GSE22537).
Additional file 2: This file lists the well substantiated genes whose
expressed increased or decreased >2-fold in at least two of three
independent experiments. Excel file presents expression data for well
substantiated genes derived from the data presented in additional file 1.
The putative function of the genes is derived from the NCBI database.
Data from 3 independent experiments for all doxycycline treatment time
points is provided.
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